UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
FORM 10-Q
(Mark One)
þ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended March 31, 2005
OR
o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from ___________ to ___________
Commission File Number 001-15166
AMERUS GROUP CO.
| IOWA | 42-1458424 | |
| (State or other jurisdiction of | (I.R.S. Employer | |
| incorporation or organization) | Identification No.) |
699 Walnut Street
Des Moines, Iowa 50309-3948
(Address of principal executive offices)
Registrants telephone number, including area code (515) 362-3600
Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes þ No o
Indicate by check mark whether the Registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act). Yes þ No o
The number of shares outstanding of each of the Registrants classes of common stock on May 2, 2005 was as follows:
Common Stock 39,172,030 shares
Exhibit index Page 39
Page 1 of 41
INDEX
2
SAFE HARBOR STATEMENT
This Quarterly Report on Form 10-Q, including the Managements Discussion and Analysis of Financial Condition and Results of Operations, contains statements which constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements relating to trends in operations and financial results and the business and the products of the Registrant and its subsidiaries, which include words such as anticipate, believe, plan, estimate, expect, intend, and other similar expressions. Forward-looking statements are made based upon managements current expectations and beliefs concerning future developments and their potential effects on the Company. Such forward-looking statements are not guarantees of future performance. Factors that may cause our actual results to differ materially from those contemplated by these forward-looking statements include, among others, the following possibilities: (a) general economic conditions and other factors, including prevailing interest rate levels and stock and bond market performance, which may affect our ability to sell our products, the market value of our investments and the lapse rate and profitability of policies; (b) our ability to achieve anticipated levels of operational efficiencies and cost-saving initiatives and to meet cash requirements based upon projected liquidity sources; (c) customer response to new products, distribution channels and marketing initiatives; (d) mortality, morbidity, and other factors which may affect the profitability of our insurance products; (e) our ability to develop and maintain effective risk management policies and procedures and to maintain adequate reserves for future policy benefits and claims; (f) changes in the federal income tax and other federal laws, regulations, and interpretations, including federal regulatory measures that may significantly affect the insurance business including limitations on antitrust immunity, minimum solvency requirements, and changes to the tax advantages offered by life insurance and annuity products or programs with which they are used; (g) increasing competition in the sale of insurance and annuities and the recruitment of sales representatives; (h) regulatory changes, interpretations, initiatives or pronouncements, including those relating to the regulation of insurance companies and the regulation and sale of their products and the programs in which they are used; (i) our ratings and those of our subsidiaries by independent rating organizations which we believe are particularly important to the sale of our products; (j) the performance of our investment portfolios; (k) the impact of changes in standards of accounting; (l) our ability to integrate the business and operations of acquired entities; (m) expected protection products and accumulation products margins; (n) the impact of anticipated investment transactions; and (o) litigation or regulatory investigations or examinations.
There can be no assurance that other factors not currently anticipated by us will not materially and adversely affect our results of operations. You are cautioned not to place undue reliance on any forward-looking statements made by us or on our behalf. Forward-looking statements speak only as of the date the statement was made. We undertake no obligation to update or revise any forward-looking statement.
3
PART I FINANCIAL INFORMATION
Item 1. Financial Statements
AMERUS GROUP CO.
| March 31, | December 31, | |||||||
| 2005 | 2004 | |||||||
| (unaudited) | ||||||||
Assets |
||||||||
Investments: |
||||||||
Securities available-for-sale at fair value: |
||||||||
Fixed maturity securities |
$ | 15,740,652 | $ | 15,646,653 | ||||
Equity securities |
76,438 | 77,024 | ||||||
Short-term investments |
2,927 | 2,979 | ||||||
Securities held for trading purposes at fair value: |
||||||||
Fixed maturity securities |
1,602,262 | 1,718,125 | ||||||
Equity securities |
534 | 15,468 | ||||||
Mortgage loans |
874,650 | 865,733 | ||||||
Policy loans |
487,915 | 486,071 | ||||||
Other investments |
367,231 | 374,240 | ||||||
Total investments |
19,152,609 | 19,186,293 | ||||||
Cash and cash equivalents |
572,185 | 478,441 | ||||||
Accrued investment income |
227,182 | 222,294 | ||||||
Premiums, fees and other receivables |
38,363 | 39,688 | ||||||
Income taxes receivable |
3,473 | | ||||||
Reinsurance receivables |
680,488 | 666,493 | ||||||
Deferred policy acquisition costs |
1,446,716 | 1,248,009 | ||||||
Deferred sales inducements |
168,630 | 137,538 | ||||||
Value of business acquired |
369,232 | 374,792 | ||||||
Goodwill |
228,869 | 226,291 | ||||||
Property and equipment |
45,777 | 46,114 | ||||||
Other assets |
302,819 | 296,409 | ||||||
Separate account assets |
233,533 | 248,507 | ||||||
Total assets |
$ | 23,469,876 | $ | 23,170,869 | ||||
See accompanying notes to consolidated financial statements.
4
AMERUS GROUP CO.
| March 31, | December 31, | |||||||
| 2005 | 2004 | |||||||
| (unaudited) | ||||||||
Liabilities and Stockholders Equity |
||||||||
Liabilities: |
||||||||
Policy reserves and policyowner funds: |
||||||||
Future life and annuity policy benefits |
$ | 18,239,450 | $ | 17,923,329 | ||||
Policyowner funds |
1,443,814 | 1,419,762 | ||||||
| 19,683,264 | 19,343,091 | |||||||
Accrued expenses and other liabilities |
965,390 | 837,514 | ||||||
Dividends payable to policyowners |
287,415 | 322,037 | ||||||
Policy and contract claims |
69,149 | 70,465 | ||||||
Income taxes payable |
| 9,299 | ||||||
Deferred income taxes |
68,666 | 145,332 | ||||||
Notes payable |
571,385 | 571,155 | ||||||
Separate account liabilities |
233,533 | 248,507 | ||||||
Total liabilities |
21,878,802 | 21,547,400 | ||||||
Stockholders equity: |
||||||||
Preferred Stock, no par value, 20,000,000 shares
authorized, none issued |
| | ||||||
Common Stock, no par value, 230,000,000 shares
authorized; 44,529,858 shares issued and
39,162,518 shares outstanding in 2005;
44,225,902 shares issued and 39,400,663 shares
outstanding in 2004 |
44,530 | 44,226 | ||||||
Additional paid-in capital |
1,204,360 | 1,198,379 | ||||||
Accumulated other comprehensive income |
34,546 | 114,670 | ||||||
Unearned compensation |
(2,700 | ) | (1,238 | ) | ||||
Retained earnings |
493,399 | 431,911 | ||||||
Treasury stock, at cost (5,367,340 shares in 2005
and 4,825,239 shares in 2004) |
(183,061 | ) | (164,479 | ) | ||||
Total stockholders equity |
1,591,074 | 1,623,469 | ||||||
Total liabilities and stockholders equity |
$ | 23,469,876 | $ | 23,170,869 | ||||
See accompanying notes to consolidated financial statements.
5
AMERUS GROUP CO.
| For The Three Months Ended March 31, | ||||||||
| 2005 | 2004 | |||||||
| (unaudited) | ||||||||
Revenues: |
||||||||
Insurance premiums |
$ | 62,546 | $ | 70,737 | ||||
Product charges |
59,033 | 49,562 | ||||||
Net investment income |
268,711 | 256,875 | ||||||
Realized/unrealized capital losses |
(48,944 | ) | (85 | ) | ||||
Other income |
12,556 | 11,702 | ||||||
| 353,902 | 388,791 | |||||||
Benefits and expenses: |
||||||||
Policyowner benefits |
169,583 | 238,429 | ||||||
Underwriting, acquisition and other expenses |
40,608 | 32,700 | ||||||
Amortization of deferred policy acquisition costs
and value of business acquired |
52,743 | 47,911 | ||||||
Dividends to policyowners |
20,003 | 25,484 | ||||||
| 282,937 | 344,524 | |||||||
Income from continuing operations |
70,965 | 44,267 | ||||||
Interest expense |
7,780 | 8,398 | ||||||
Income before income tax expense |
63,185 | 35,869 | ||||||
Income tax expense |
1,697 | 6,129 | ||||||
Net income from continuing operations |
61,488 | 29,740 | ||||||
Income from discontinued operations, net of tax |
| 3,899 | ||||||
Net income before cumulative effect of change in accounting |
61,488 | 33,639 | ||||||
Cumulative effect of change in accounting, net of tax |
| (510 | ) | |||||
Net income |
$ | 61,488 | $ | 33,129 | ||||
Net income from continuing operations per common share: |
||||||||
Basic |
$ | 1.55 | $ | 0.76 | ||||
Diluted |
$ | 1.43 | $ | 0.74 | ||||
Net income per common share: |
||||||||
Basic |
$ | 1.55 | $ | 0.84 | ||||
Diluted |
$ | 1.43 | $ | 0.82 | ||||
Weighted average common shares outstanding: |
||||||||
Basic |
39,575,696 | 39,263,367 | ||||||
Diluted |
42,930,905 | 40,434,902 | ||||||
See accompanying notes to consolidated financial statements.
6
AMERUS GROUP CO.
| For The Three Months Ended March 31, | ||||||||
| 2005 | 2004 | |||||||
| (unaudited) | ||||||||
Net income |
$ | 61,488 | $ | 33,129 | ||||
Other comprehensive income (loss), before tax: |
||||||||
Unrealized gains (losses) on securities: |
||||||||
Unrealized holding gains (losses) arising during period |
(123,642 | ) | 88,879 | |||||
Reclassification adjustment for (gains) losses
included in net income |
374 | 17,453 | ||||||
Other comprehensive income (loss), before tax |
(123,268 | ) | 106,332 | |||||
Income tax (expense) benefit related to items of other
comprehensive income |
43,144 | (37,216 | ) | |||||
Other comprehensive income (loss), net of taxes |
(80,124 | ) | 69,116 | |||||
Comprehensive income (loss) |
$ | (18,636 | ) | $ | 102,245 | |||
See accompanying notes to consolidated financial statements.
7
AMERUS GROUP CO.
| Accumulated | ||||||||||||||||||||||||||||
| Additional | Other | Total | ||||||||||||||||||||||||||
| Paid-In | Comprehensive | Unearned | Retained | Treasury | Stockholders | |||||||||||||||||||||||
| Common Stock | Capital | Income | Compensation | Earnings | Stock | Equity | ||||||||||||||||||||||
Balance at December 31, 2003 |
$ | 43,836 | $ | 1,184,237 | $ | 84,519 | $ | (1,361 | ) | $ | 255,006 | $ | (156,426 | ) | $ | 1,409,811 | ||||||||||||
2004: |
||||||||||||||||||||||||||||
Net income |
| | | | 192,642 | | 192,642 | |||||||||||||||||||||
Net unrealized gain on securities |
| | 33,959 | | | | 33,959 | |||||||||||||||||||||
Net unrealized gain on derivatives
designated as cash flow hedges |
| | 420 | | | | 420 | |||||||||||||||||||||
Stock issued under various incentive
plans, net of forfeitures |
390 | 14,142 | | 123 | | 1,100 | 15,755 | |||||||||||||||||||||
Purchase of treasury stock |
| | | | | (9,153 | ) | (9,153 | ) | |||||||||||||||||||
Dividends declared on common stock |
| | | | (15,737 | ) | | (15,737 | ) | |||||||||||||||||||
Minimum pension liability adjustment |
| | (4,228 | ) | | | | (4,228 | ) | |||||||||||||||||||
Balance at December 31, 2004 |
44,226 | 1,198,379 | 114,670 | (1,238 | ) | 431,911 | (164,479 | ) | 1,623,469 | |||||||||||||||||||
2005 (unaudited): |
||||||||||||||||||||||||||||
Net income |
| | | | 61,488 | | 61,488 | |||||||||||||||||||||
Net unrealized loss on securities |
| | (80,018 | ) | | | | (80,018 | ) | |||||||||||||||||||
Net unrealized loss on derivatives
designated as cash flow hedges |
| | (106 | ) | | | | (106 | ) | |||||||||||||||||||
Stock issued under various incentive
plans, net of forfeitures |
304 | 5,981 | | (1,462 | ) | | 996 | 5,819 | ||||||||||||||||||||
Purchase of treasury stock |
| | | | | (19,578 | ) | (19,578 | ) | |||||||||||||||||||
Balance at March 31, 2005 |
$ | 44,530 | $ | 1,204,360 | 34,546 | $ | (2,700 | ) | $ | 493,399 | $ | (183,061 | ) | $ | 1,591,074 | |||||||||||||
See accompanying notes to consolidated financial statements.
8
AMERUS GROUP CO.
| For The Three Months Ended March 31, | ||||||||
| 2005 | 2004 | |||||||
| (unaudited) | ||||||||
Cash flows from operating activities |
||||||||
Net income |
$ | 61,488 | $ | 33,129 | ||||
Adjustments to reconcile net income to net cash
provided by operating activities: |
||||||||
Cumulative effect of change in accounting |
| 510 | ||||||
Gain on sale of discontinued operations |
| (3,899 | ) | |||||
Product charges |
(59,033 | ) | (49,562 | ) | ||||
Interest credited to policyowner account
balances |
128,781 | 120,594 | ||||||
Change in option value of indexed products
and market value adjustments on total
return strategy annuities |
(44,334 | ) | 23,733 | |||||
Realized/unrealized capital (gains) losses |
48,944 | 85 | ||||||
DAC and VOBA amortization |
52,743 | 47,911 | ||||||
DAC and VOBA capitalized |
(114,527 | ) | (88,790 | ) | ||||
Change in: |
||||||||
Accrued investment income |
(4,888 | ) | (9,566 | ) | ||||
Reinsurance receivables |
(35,861 | ) | (18,370 | ) | ||||
Securities held for trading purposes: |
||||||||
Fixed maturities |
74,126 | 82,999 | ||||||
Equity securities |
14,913 | (4,029 | ) | |||||
Liabilities for future policy benefits |
(44,876 | ) | (32,635 | ) | ||||
Accrued expenses and other liabilities |
108,299 | 161,338 | ||||||
Policy and contract claims and other
policyowner funds |
21,492 | 48,237 | ||||||
Income taxes: |
||||||||
Current |
(12,771 | ) | 24,953 | |||||
Deferred |
(32,304 | ) | (17,710 | ) | ||||
Other, net |
12,632 | (18,003 | ) | |||||
Net cash provided by operating activities |
174,824 | 300,925 | ||||||
Cash flows from investing activities: |
||||||||
Purchase of fixed maturities available-for-sale |
(1,225,650 | ) | (1,491,077 | ) | ||||
Proceeds from sale of fixed maturities available-for-sale |
503,684 | 892,538 | ||||||
Maturities, calls and principal reductions of
fixed maturities available-for-sale |
322,205 | 293,607 | ||||||
Purchase of equity securities |
(681 | ) | (37,116 | ) | ||||
Proceeds from sale of equity securities |
880 | 35,962 | ||||||
Change in short-term investments, net |
982 | 10,503 | ||||||
Purchase of mortgage loans |
(42,365 | ) | (24,268 | ) | ||||
9
AMERUS GROUP CO.
CONSOLIDATED STATEMENTS OF CASH FLOWS (Continued)
($ in thousands)
| For The Three Months Ended March 31, | ||||||||
| 2005 | 2004 | |||||||
| (unaudited) | ||||||||
Proceeds from repayment and sale of mortgage loans |
33,187 | 148,101 | ||||||
Purchase of other invested assets |
(25,868 | ) | (80,971 | ) | ||||
Proceeds from sale of other invested assets |
19,385 | 31,942 | ||||||
Change in policy loans, net |
(1,844 | ) | 4,402 | |||||
Proceeds from sale of discontinued operations |
| 15,000 | ||||||
Other assets, net |
(6,075 | ) | 3,793 | |||||
Net cash used in investing activities |
(422,160 | ) | (197,584 | ) | ||||
Cash flows from financing activities: |
||||||||
Deposits to policyowner account balances |
744,034 | 508,716 | ||||||
Withdrawals from policyowner account balances |
(409,003 | ) | (429,342 | ) | ||||
Change in debt, net |
230 | (50,500 | ) | |||||
Stock issued under various incentive plans, net of
forfeitures |
5,819 | 3,164 | ||||||
Net cash provided by financing activities |
341,080 | 32,038 | ||||||
Net increase in cash |
93,744 | 135,379 | ||||||
Cash and cash equivalents at beginning of period |
478,441 | 274,150 | ||||||
Cash and cash equivalents at end of period |
$ | 572,185 | $ | 409,529 | ||||
Supplemental disclosure of cash activities: |
||||||||
Interest paid |
$ | 8,738 | $ | 7,818 | ||||
Income taxes paid |
$ | 43,044 | $ | 78 | ||||
Supplemental disclosure of non-cash operating activities: |
||||||||
Capitalization of deferred sales inducements |
$ | 22,418 | $ | 11,362 | ||||
Supplemental disclosure of non-cash financing activities: |
||||||||
Accrual of treasury stock purchases |
$ | 19,578 | $ | | ||||
See accompanying notes to consolidated financial statements.
10
AMERUS GROUP CO.
(1) CONSOLIDATION AND BASIS OF PRESENTATION
The accompanying unaudited consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (GAAP) for interim financial information and the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for annual financial statements. In the opinion of management, all adjustments considered necessary for a fair presentation have been included. All adjustments were of a normal recurring nature, unless otherwise noted in the Notes to Consolidated Financial Statements. Operating results for the three months ended March 31, 2005 are not necessarily indicative of the results that may be expected for the year ending December 31, 2005. The consolidated balance sheet at December 31, 2004 has been derived from the audited financial statements at that date but does not include all of the information and footnotes required by GAAP for complete financial statements. For further information and for capitalized terms not defined in this Form 10-Q, refer to the consolidated financial statements and notes thereto included in the Companys Annual Report on Form 10-K for the year ended December 31, 2004.
The accompanying consolidated financial statements include the accounts and operations of the Company and its wholly-owned subsidiaries, principally AmerUs Life Insurance Company (ALIC), AmerUs Annuity Group Co. and its subsidiaries (collectively, AAG), AmerUs Capital Management Group, Inc. (ACM), and ILICO Holdings, Inc., the holding company of Indianapolis Life Insurance Company (ILIC) and its subsidiaries (collectively, ILICO). All significant intercompany transactions and balances have been eliminated in consolidation.
The Company has certain stock-based employee compensation plans which are accounted for under the recognition and measurement principles of APB Opinion No. 25, Accounting for Stock Issued to Employees, and related interpretations. The plans are stock option plans for which no stock-based employee compensation cost is reflected in net income, as all options granted under those plans had an exercise price equal to the market value of the underlying common stock on the date of grant. The following table illustrates the effect on net income and earnings per share if the Company had applied the fair value recognition provisions of Statement of Financial Accounting Standards (SFAS) 123, Accounting for Stock-Based Compensation, to stock-based employee compensation:
11
| For The Three Months Ended March 31, | ||||||||
| 2005 | 2004 | |||||||
| ($ in thousands, except share data) | ||||||||
Net income, as reported |
$ | 61,488 | $ | 33,129 | ||||
Deduct: Total stock-based employee compensation
expense determined under fair value based method
for all awards, net of related tax effects |
(659 | ) | (1,162 | ) | ||||
Pro forma net income |
$ | 60,829 | $ | 31,967 | ||||
Earnings per share: |
||||||||
Basic as reported |
$ | 1.55 | $ | 0.84 | ||||
Basic pro forma |
$ | 1.54 | $ | 0.81 | ||||